Companies: 10,795·Total market cap: $144.5T
Burcon NutraScience Corporation

Burcon NutraScience Corporation

BU.TOTSXConsumer Defensive● Active
$1.86
$-0.12(-6.06%)
Market Cap$23607633
P/E Ratio
52W High$5
52W Low$1.51
Overview

Burcon NutraScience Corporation (BU.TO) Revenue

Annual & quarterly revenue history · segment & region breakdown

BU.TO · revenue · updated Jun 8, 2026

Core revenue metrics

Burcon NutraScience Corporation trailing twelve-month (TTM) revenue is $0.00B, an increase of 106.88% year-over-year from $0.00B in FY2025.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+106.88%
vs FY2025 $0.00B
Price / sales
15.94×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$59K
25 employees
FY2025
$0.00B
FY2024
$0.00B
5Y CAGR
+8.1%
Fiscal year end
Dec 31
Currency
CAD · GAAP
Filing
10-K / 10-Q
Source: FMP · Burcon NutraScience Corporation SEC filings · GAAPUpdated: 2026-06-08

Revenue trend

20252006 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-03-31$0.00B+$0.00B+106.88%
2024-03-31$0.00B-$0.00B-49.34%
2023-03-31$0.00B+$0.00B+112.23%
2022-03-31$0.00B-$0.00B-33.70%
2021-03-31$0.00B+$0.00B+730.75%
2020-03-31$0.00B-$0.00B-22.51%
2019-03-31$0.00B-$0.00B-18.03%
2018-03-31$0.00B-$0.00B-44.20%
2017-03-31$0.00B-$0.00B-17.44%
2016-03-31$0.00B+$0.00B+0.95%
BU.TO revenue by year · BU.TO revenue history · BU.TO annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Burcon NutraScience Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Burcon NutraScience Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.

Data sourced from Burcon NutraScience Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

BU.TO revenue · 4 questions

BU.TO's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 106.88% year-over-year from $0.00B in FY2025.

BU.TO revenueBU.TO annual revenuewhat is BU.TO revenueBU.TO TTM revenue

Source: FMP · Burcon NutraScience Corporation SEC filings · GAAP · Burcon NutraScience Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026